FMC CORP (FMC) 110.76 -1.21 (-1.08%)
110.76 -1.21 (-1.08%)
US3024913036 - Common Stock - After market: 110.76 0 (0%)
Fundamental Rating
We assign a fundamental rating of 4 out of 10 to FMC. FMC was compared to 120 industry peers in the Chemicals industry. FMC has a medium profitability rating, but doesn't score so well on its financial health evaluation. FMC is quite expensive at the moment. It does show a decent growth rate.
Profitability
Profitability Rating
FMC has a Profit Margin of 12.80%. This is better than the industry average of 6.51%.
FMC's Return On Assets of 6.27% is in line with the rest of the industry. The industry average Return On Assets is 4.76%.
FMC has a Return On Equity of 22.28%. This is comparable to the industry average of 18.92%.
FMC has a Piotroski-F score of 6.00. This indicates an average health and profitability for FMC.
VS Industry
ROA (6.27%) VS Industry: 57% outperformed.
-1,527.37
271.00
ROE (22.28%) VS Industry: 55% outperformed.
1.71
192.48
Profit Margin (12.8%) VS Industry: 76% outperformed.
-160,314.80
86.52
Valuation
Valuation Rating
The Price/Earnings Ratio is 14.97, which indicates a correct valuation of FMC.
The Forward Price/Earnings Ratio of 12.97 indicates a correct valuation of FMC.
The PEG Ratio, which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
With a price book ratio of 4.49, FMC is valued correctly.
FMC's Price/Earning Ratio is slightly more expensive than the industry average, which is at 9.35.
Compared to an average industry price book ratio of 1.74, FMC is valued more expensive than its industry peers. 85% of the companies listed in the same industry are valued cheaper.
Compared to an average industry Enterprise Value to EBITDA ratio of 8.14, FMC is valued more expensive than its industry peers.
VS Industry
Price/Earnings (14.97) VS Industry: 28% outperformed.
64.02
2.14
Price/Book (4.49) VS Industry: 15% outperformed.
26.10
0.05
Enterprise Value/ EBITDA (11.77) VS Industry: 29% outperformed.
60.09
1.64
Growth
Growth Rating
FMC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 23.75%, which is quite impressive.
Measured over the past 5 years, FMC shows a quite strong growth in Earnings Per Share. The EPS has been growing by 19.70% on average per year.
The Earnings Per Share is expected to grow by 11.72% on average over the next 5 years. This is quite good.
The Revenue has grown by 15.75% in the past year. This is quite good.
FMC shows quite a strong growth in Revenue. Measured over the last 5 years, the Revenue has been growing by 14.72% yearly.
Based on estimates for the next 5 years, FMC will show a small growth in Revenue. The Revenue will grow by 6.32% on average per year.
When comparing the EPS growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.
The Revenue growth is decreasing: in the next 5 years the growth will be less than in the last years.
| Past | Future | ||||||
|---|---|---|---|---|---|---|---|
| 5Y | 3Y | 1Y | 1Y | 2Y | 3Y | 5Y | |
| EPS | 19.7% | 3.28% | 23.75% | 8.34% | 11% | 11.34% | 11.72% |
| Revenue | 14.72% | 5.59% | 15.75% | 12.56% | 8.77% | 7.52% | 6.32% |
Health
Health Rating
FMC has a Current Ratio of 1.38. This is a normal value and indicates that FMC is financially healthy and should not expect problems in meeting its short term obligations.
An Altman-Z score of 2.63 indicates that FMC is not a great score, but indicates only limited risk for bankruptcy at the moment.
FMC has a Altman-Z score comparable to the industry average, which is at 2.76.
The Piotroski-F score of FMC is 6.00. This is a neutral score and indicates average health and profitability for FMC.
Compared to an average industry Current Ratio of 2.16, FMC is worse placed to pay its short term obligations than its industry peers.
FMC has a Quick Ratio of 1.38. This is a bad value and indicates that FMC is not financially healthy enough and could expect problems in meeting its short term obligations.
When comparing the Quick Ratio of FMC to the average industry Current Ratio of 1.33, FMC is less able to pay its short term obligations than its industry peers.
When comparing the Debt to Equity Ratio of FMC to the average industry Debt to Equity Ratio of 0.53, FMC required more debt to finance its operations than its industry peers.
VS Industry
Debt/Equity (0.88) VS Industry: 33% outperformed.
7.55
0.00
Quick Ratio (0.99) VS Industry: 27% outperformed.
0.00
61.35
Current Ratio (1.38) VS Industry: 22% outperformed.
0.00
61.35
Altman-Z (2.63) VS Industry: 47% outperformed.
-1,435.77
110.00
Dividend
Dividend Rating
The dividend of FMC is nicely growing with an annual growth rate of 42.75%!
FMC pays out 37.05% of its income as dividend. This is a sustainable payout ratio.
FMC has paid a dividend for at least 10 years, which is a reliable track record.
With a Yearly Dividend Yield of 2.02%, FMC has a reasonable but not impressive dividend return.
FMC's Dividend Yield is slightly below the industry average, which is at 2.60.
FMC's Dividend Yield is slightly below the S&P500 average, which is at 2.63.
FMC's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
VS Industry
Dividend Yield (2.02%) VS Industry: 38% outperformed.
0.39
24.34
FMC CORP110.76
NYSE:FMC (10/7/2022, 6:00:00 PM)-1.21 (-1.08%)
| GICS Sector | Materials | ||
| GICS IndustryGroup | Materials | ||
| GICS Industry | Chemicals | ||
| Earnings (Last) | 08-02 2022-08-02/amc | Earnings (Next) | 10-31 2022-10-31 |
| Ins Owners | 0.49% | Inst Owners | 89.83% |
| Market Cap | 13.95B | Analysts | 74.4 |
| PE | 14.97 | Fwd PE | 12.97 |
| PEG (NY) | 1.79 | PEG (5Y) | 0.76 |
| P/S | 2.58 | P/B | 4.49 |
| EV/EBITDA | 11.77 | ||
| Dividend Yield | 2.02% | Dividend Growth | 42.75% |
| DP | 37.05% | Ex-Date | 09-29 2022-09-29 (0.53) |
| EPS 1Y | 23.75% | EPS 3Y | 3.28% |
| EPS 5Y | 19.7% | EPS growth Q2Q | 6.63% |
| EPS Next Y | 8.34% | EPS Next 2Y | 11% |
| EPS Next 3Y | 11.34% | EPS Next 5Y | 11.72% |
| Revenue growth 1Y | 15.75% | Revenue growth 3Y | 5.59% |
| Revenue growth 5Y | 14.72% | Revenue growth Q2Q | 16.93% |
| Revenue Next Year | 12.56% | Revenue Next 2Y | 8.77% |
| Revenue Next 3Y | 7.52% | Revenue Next 5Y | 6.32% |
| Current Ratio | 1.38 | Quick Ratio | 0.99 |
| Altman-Z | 2.63 | F-Score | 6 |
| Debt/Equity | 0.88 | WACC | 8.69% |
| ROIC/WACC | 2.65 | ||
| ROA | 6.27% | ROE | 22.28% |
| ROIC | 23.02% | ROICg | 11.96% |
| PM | 12.8% | OM | 21.25% |
| Asset Turnover | 0.49 | ||
Fundamental Stock Screener Links
Fundamental Stock Screener
Find stocks with similar Fundamental rating on the USA
Best Fundamental Competitors Stock Screener
Find the competitors with the best fundamentals on the USA
Best Valuation Competitors Stock Screener
Find the competitors with the best valuation on the USA
Best Dividend Competitors Stock Screener
Find the competitors with the best dividend on the USA